Literature DB >> 30066159

Peptiduria: a potential early predictor of diabetic kidney disease.

Krishnamurthy P Gudehithlu1, Peter D Hart2,3,4, Jane Vernik2,3, Periannan Sethupathi5, George Dunea2,5,4, Jose A L Arruda2,5,4, Ashok K Singh2,5,4.   

Abstract

BACKGROUND: To protect the kidney effectively with medication in type 2 diabetics, it is crucial to identify such at-risk patients early for treatment. We investigated whether peptiduria precedes proteinuria (the earliest urinary marker in our model), and thereby serve as an early predictor of diabetic nephropathy.
METHODS: A longitudinal study was performed in a rat model of diabetic nephropathy. Peptides, defined as degradation products of proteins of < 13 kD size, were quantified by a previously validated method using a combination of Lowry and Biorad protein assays. Peptides in urine were also confirmed by chromatographically separating low molecular weight fractions from urine and quantifying albumin fragments in these fractions by enzyme immunoassay. Also, the mechanism of peptiduria was addressed by measuring acid phosphatase, a marker of lysosomal activity, in urine and on kidney sections (histochemically).
RESULTS: In rats with diabetic nephropathy, proteinuria occurred after 12 weeks of diabetes, while peptiduria occurred as early as 2 weeks after diabetes. Peptiduria was confirmed by showing that the chromatographically separated low molecular weight fractions of urine containing albumin fragments is in proportion to the level of peptiduria. The time course of peptiduria paralleled the increase in urinary acid phosphatase suggesting that the mechanism of early peptiduria could be due to upregulation of lysosomal enzyme activity in the tubules.
CONCLUSIONS: Our results showing that peptiduria precedes proteinuria in diabetic nephropathy provide a compelling rationale to perform a prospective human clinical trial to investigate whether peptiduria can serve as an early predictor of diabetic nephropathy.

Entities:  

Keywords:  Acid phosphatase; Diabetic nephropathy; Histochemistry; Peptiduria; Proteinuria

Mesh:

Substances:

Year:  2018        PMID: 30066159     DOI: 10.1007/s10157-018-1620-0

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  4 in total

1.  Flavonoids interference in common protein assays: Effect of position and degree of hydroxyl substitution.

Authors:  Rashim Singh; Rong Lu; Ming Hu
Journal:  Anal Biochem       Date:  2020-02-24       Impact factor: 3.191

2.  The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes.

Authors:  Deyuan Zhang; Shandong Ye; Tianrong Pan
Journal:  PeerJ       Date:  2019-06-11       Impact factor: 2.984

3.  Spatiotemporal organisation of protein processing in the kidney.

Authors:  Marcello Polesel; Monika Kaminska; Dominik Haenni; Milica Bugarski; Claus Schuh; Nevena Jankovic; Andres Kaech; Jose M Mateos; Marine Berquez; Andrew M Hall
Journal:  Nat Commun       Date:  2022-09-29       Impact factor: 17.694

4.  Differential Urinary Proteome Analysis for Predicting Prognosis in Type 2 Diabetes Patients with and without Renal Dysfunction.

Authors:  Hee-Sung Ahn; Jong Ho Kim; Hwangkyo Jeong; Jiyoung Yu; Jeonghun Yeom; Sang Heon Song; Sang Soo Kim; In Joo Kim; Kyunggon Kim
Journal:  Int J Mol Sci       Date:  2020-06-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.